Deepica Reddy, MD
Internal Medicine · Jacksonville, FLNPI 1841262318
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,759 of the $4,959 with a category attached, or 75.8%. 30 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 26.9% of the total. Reporting peaked in 2021 at $2,317 and has fallen 89.5% since, to $243 in 2024. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 219 payments — averaging $22.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- Novo Nordisk$663
- AbbVie$362
- AstraZeneca$355
- Pfizer$308
- Amgen$289
- plus $2K from 24 others
What the payments were for
- Consulting fees$1,20024%
- Food & beverage$3,75976%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 6 | $1,334 |
| Novo Nordisk | 46 | $663 |
| AbbVie(2 entities) | 23 | $362 |
| AstraZeneca | 22 | $355 |
| Pfizer | 16 | $308 |
| Amgen(2 entities) | 17 | $289 |
| Lilly USA, LLC | 15 | $224 |
| Boehringer Ingelheim | 13 | $207 |
| Edwards Lifesciences | 2 | $207 |
| Amarin Pharma, Inc. | 5 | $101 |
| GSK | 5 | $101 |
| Abbott | 4 | $74 |
| Johnson & Johnson | 5 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $64 |
| Merck | 4 | $62 |
| Kowa Pharmaceuticals America, Inc. | 4 | $60 |
| Novartis | 3 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $57 |
| Bayer | 2 | $48 |
| Daiichi Sankyo Inc. | 3 | $47 |
| Arbor Pharmaceuticals, Inc. | 3 | $44 |
| Eisai Inc. | 3 | $40 |
| Sanofi Pasteur Inc. | 1 | $24 |
| Dynavax Technologies Corporation | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,959 in reported general payments places this provider in the 90th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 21 | $160 |
| Atorvastatin Calcium | 15 | $102 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Jacksonville
- Daniela Chiriboga SalazarJacksonville$117K
- James PorcelliJacksonville$61K
- Reza HejaziJacksonville$44K
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.